![Begoña Carreño-Gomez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Begoña Carreño-Gomez
Directeur/Membre du Conseil chez
PROQR THERAPEUTICS N.V.
Fortune : - $ au 31/05/2026
Profil
Begoña Carreño-Gomez is currently an Independent Member of the Supervisory Board at ProQR Therapeutics NV since 2023.
Dr. Carreño-Gomez also serves as Chief Business Development Officer at Vectura Fertin Pharma, Inc. Formerly, Dr. Carreño-Gomez was Head of World Wide BD&L at Novartis Pharma AG.
Education includes an undergraduate degree from Keele University and a doctorate from UCL School of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Begoña Carreño-Gomez
| Sociétés | Poste | Début |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Directeur/Membre du Conseil | 01/01/2023 |
Vectura Fertin Pharma, Inc. | Corporate Officer/Principal | - |
Anciens postes connus de Begoña Carreño-Gomez
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Formation de Begoña Carreño-Gomez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Keele University
 Keele University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
UCL School of Pharmacy
 UCL School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vectura Fertin Pharma, Inc. |
Choisissez Zonebourse 
